Press Releases
March 7, 2019
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2018
March 4, 2019
Surface Oncology to Present at the 39th Annual Cowen Healthcare Conference
February 4, 2019
Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388
January 16, 2019
Publication in ImmunoHorizons Highlights the Role of IL-27 in Upregulation of Multiple Checkpoint Proteins
January 4, 2019
Surface Oncology Announces Appointment of F. Stephen Hodi, MD to its Scientific Advisory Board